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BY-NC-ND license (http://creativecoSummary Introduction: One of the great challenges in pancreas transplantation is the
ischemia reperfusion injury. It is mentioned that free oxygen and/or nitrogen radicals play a
prominent role in this phase. To minimize this problem, a modified histidineetryptophan
eketoglutarate (HTK) solution that contains modified antioxidants has been developed. Our
aim was to evaluate this solution in improving the viability of the pancreas in comparison with
standard HTK and University of Wisconsin (UW) solutions in a porcine model of pancreas trans-
plantation.
Materials and methods: Twenty-three Landrace pigs were divided into three identical groups.
After a 10-hour preservation time at 4C, the pancreas was implanted in the organs of the recip-
ients in a standardizedmanner. Serum parameters were assessed prior to and after implantation
on the 1st postoperative day, 3rd postoperative day, and 7th postoperative day. Furthermore,
three biopsies were taken: prior to and after reperfusion, and on Day 7 to assess the grafts.
Results: An analysis of serum glucose among the three groups showed no significant differences.
Evaluation of the insulin levels showed no significant difference between the modified anddeclare that they have no competing interests.
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Modified HTK in PTx 67standard HTK groups; however, differences between HTK and UW were significant (pZ 0.004 in
favor ofUWsolutions). Thehistopathological results showeda trendof a higher gradeof rejection
of pancreas tissue in the UW group compared to both HTK groups.
Conclusion: The modified HTK solution could preserve the pancreas for the preservation of the
graft with similar results to those observed for standard solutions without any significant differ-
ence. The trend showed that the pathological finding in the UW group was not as good as that in
the modified HTK and standard HTK groups.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
In experimental studies, a procured pancreas has been re-
ported to tolerate cold storage for a maximum of 72 hours,1
but clinically, according to the United Network for Organ
Sharing and the International Pancreas Transplant Registry
reports, 75% of the grafts are preserved for <18 hours to
reduce the possibility of ischemia reperfusion injury (IRI).2
As shown in pancreas transplantation (PTx), IRI is corre-
lated with acute rejection rate, primary graft dysfunction,
delayed graft function, and late graft failure.3 IRI is also the
main cause of graft pancreatitis, known as the most sig-
nificant complication of PTx and seen in up to 35% of
recipients.4e6 Today, the two most commonly used pres-
ervation solutions in PTx are University of Wisconsin (UW)
and histidineetryptophaneketoglutarate (HTK) solu-
tions.7,8 UW solution was the gold standard for perfusion
and storage in clinical multiorgan procurement prior to the
approval of HTK.9e11 Today, HTK is being used commonly
for kidney,12 liver,13 cardiac,14 and PTx.15 The benefits of
HTK compared to UW include better tissue perfusion
because of its lower viscosity, decreased risk of reperfusion
hyperkalemia, favorable cell preservation over a wider
range of temperatures,7 easy handling, and lower cost.1 By
contrast, some studies have noted that HTK preservation is
associated with a 30% increased risk of graft loss when
compared with UW,7 and a trend of poorer graft survival
was shown with HTK preservation at 30 days.9 In addition,
some recent experiments have reported that allografts
preserved in HTK may be more edematous than those
stored in UW.7,16,17
It seems that, in HTK solutions, as hypothesized by
Rauen et al18 using rats, histidine in combination with hy-
pothermia increases the formation of intracellular iron-
dependent reactive oxygen radicals. Therefore, to reduce
the oxidative stress, recent efforts have introduced a
modified HTK solution19 supplemented by two main modi-
fications: decreasing the production of reactive iron-
dependent oxygen radicals by replacing a part of histidine
with nontoxic N-acetyl-L-histidine18 and enhancing a
favorable capacity of chelating-free iron components by
using a combination of different chelators such as defer-
oxamine and LK-614.20 Deferoxamine is a traditional, well-
evaluated iron chelator, which has been experienced pre-
viously in other preservation solutions.21 LK-614 as a lipo-
philic but weaker iron chelator19 has also been
incorporated in modified HTK, considering the fact that LK-614 with better membrane permeability protects the organ
from iron-dependent cell injuries.20 For evaluating this
solution, we assess the modified HTK preservation solution
with reduced disadvantages by better radical scavenger
capacity and compare it with standard HTK and UW solu-
tions in a porcine model of PTx.2. Materials and methods
2.1. Experimental design
Forty-six Landrace pigs with a body weight of 30e40 kg
were randomized into three groups: UW (7 donors, 7 re-
cipients), modified HTK (8 donors, 8 recipients), and stan-
dard HTK (8 donors, 8 recipients). The simplified technique
of PTx in a porcine model was produced as previously
described.22 In each group, after perfusion with the
respective solution and a 10-hour preservation at 4C, the
organs were implanted in the recipient pigs through a
standardized technique. The recipients were observed for 7
days, and then the final evaluation was performed after
relaparotomy. All animals were scarified after completing
the experiments (Figure 1).
2.2. Anesthesia
Twelve hours before the experiments, the animal’s food
intake had been restricted, but they had free access to
water. Ketamine (5 mg/kg; Ketanes; Parke-Davis/Pfizer,
Karlsruhe, Germany), azaperone (8 mg/kg; Stresnil;
Jansen-Cilag, Neuss, Germany), and midazolam (0.5 mg/kg;
Dormicum; Hoffmann-La Roche, Grenzach-Wyhlen, Ger-
many) were administered as premedication 15 minutes
prior to anesthesia. Anesthesia was induced with ketamine
[5 mg/kg, intravenously (i.v.)], midazolam (0.1 mg/kg,
i.v.), and atropine (0.04 mg/kg, i.v.; Atropium sulfuricum;
Eifelfango, Bad Neuenahr, Germany). The animals were
intubated and ventilated with a mixture of 1.5e2.0 L/min
oxygen, 0.5e1.0 L/min air, and 0.75e1.5% isoflurane (Isu-
floran, Baxter, Unterschleißem, Germany).
2.3. Surgical procedure
All operations were performed by the same surgical team,
as in the case of experimental PTx.
Figure 1 Study design from the graft procurement to final evaluation of the transplanted pancreas.
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Under general anesthesia and after midline laparotomy, the
pancreas was mobilized, and the main supplying vessels
(abdominal aorta and portal vein) were dissected gently. The
common hepatic and left gastric artery with the common
bile duct were isolated. Ten minutes prior to the perfusion,
20,000 IU heparin was intravenously injected. A perfusion
catheter was placed proximally into the iliac bifurcation,
and the abdominal aorta was blocked proximal to the celiac
trunk. Perfusing of the organs was made through the former
cannula with one of the following preservation solutions: (1)
UW solution (ViaSpan, Bristol Mayers Squibb & Co. KGA,
Mu¨nchen, Germany; n Z 7); (2) modified HTK solution
(Custodiol-N; Dr F. Ko¨hler Chemie GmbH, Alsbach-Hahnlein,
Germany; nZ 8); and (3) standard HTK solution (Custodiol;
Dr F. Kohler Chemie GmbH; nZ 8).
Two liters of HTK solution, either standard ormodified, or
750mL of UW solutionwas used for flushing out the graft with
a controlled pressure of 120 mmHg at 4C. At the end of the
perfusion, the portal vein was divided. An aortic tube graft
including the celiac trunk and the superiormesenteric artery
was obtained for the arterial anastomosis. The proximal and
distal parts of the duodenum were cut with a linear stapler
(Multifire GIA 60, Covidien, MN, USA). Finally, the pancreas
graft with its duodenum was removed (Figure 2). The organs
were placed in a preservation solution at 4C for 10 hours.
2.3.2. Total pancreatectomy and graft implantation
After anesthesia induction, a venous catheter was inserted
from the left external jugular vein, and an arterial catheter
was placed in the common carotid artery. The meanFigure 2 An explanted pancreas with the prepared vessels
(aZ aortic graft; b Z portal vein; cZ duodenum) after a 10-
hour cold ischemia time.arterial pressure (MAP), heart rate, electrocardiogram,
SaO2, and rectal temperature were monitored during the
operation. A median abdominal incision was applied. Next,
a duodenum preserving total native pancreatectomy was
performed. After a 10-hour cold ischemia time, the pro-
cured pancreas graft was placed heterotopically in the right
abdominal fossa for easy access to the main abdominal
vessels. The aorta graft, which had been prepared previ-
ously, was used for an end-to-side anastomosis to the
recipient aorta with continuous single-layer sutures (pro-
lene 5/0). A similar end-to-side anastomosis between the
graft portal vein and the recipient inferior vena cava was
constructed (prolene 6/0). Prior to the pancreas graft
reperfusion, heparin (200 IU/kg, i.v.) was administered to
avoid coagulation in the organ vessels. The reperfusion
started with removing the venous and arterial clamps,
respectively. Finally, the donor duodenum was anatomized
to the recipient’s duodenum with 5/0 polydioxanon in an
end-to-side manner (Figure 3). During the operations, all
recipients received 5 mL/min isotonic solution infusions
(NaCl 0.9% or Ringer), 2 mL (i.v.) metamidazole (Novalgin;
Sanofi-Aventis, Frankfurt, Germany), 2.5 mL (i.v.) enro-
floxacin (Baytril; Bayer, Leverkusen, Germany), and 20 mg
(i.v.) pantazol (Takeda, Berlin, Germany).2.4. Postoperative management and relaparotomy
The recipients were observed for 7 days and visited two
times daily. They received 20 mL/kg/d (i.v.) fluid infusion
(NaCl 0.9% or Ringer). Also, for immunosuppressive therapy,
250 mg/d (i.v.) methylprednisolone (Urbason; Sanofi-Figure 3 The implanted pancreas graft 10 minutes after
reperfusion.22
Modified HTK in PTx 69Avenits) and 0.05 mg/kg/d (i.v.) tacrolimus (Prograf; Fuji-
sawa, Mu¨nchen, Germany) were administered. In addition,
pantazol (20 mg/d, i.v.), enoxaparin (40 mg/d, subcuta-
neously) (Clexane; Aventis, Frankfurt, Germany), and
enrofloxacin (2.5 mg/kg/d, i.v.) were administered for
stress ulcers, vascular thrombosis, and infection prophy-
laxis, respectively. Finally, a relaparotomy was performed
under deep anesthesia on Day 7 for transplant pancrea-
tectomy; subsequently, the animals were sacrificed using
2 mmol/kg (i.v.) of potassium chloride.
2.5. Measurement protocol
Five blood samples were obtained at predefined time points
(after graft procurement, 10 minutes after reperfusion, and
also on the 1st day, 3rd day, and 7th days after implantation)
for evaluation of serum insulin (ng/mL), glucose (mg/dL),
hemoglobin (g/dL), hematocrit (%), amylase (U/L), lipase
(U/L), and C-reactive protein (mg/L). Insulin level was
analyzed with a specific insulin kit for pigs (Porcine Insulin
Elisa; Mercodia AB, Uppsala, Sweden).
2.6. Histopathological evaluation
Three biopsies were taken at the end of the cold ischemia
time: prior to reperfusion, after reperfusion, and 7 days
after the operation. All samples were fixed in formaldehyde
5% and evaluated by a pathologist. As reported by Dra-
chenberg et al,23 the histomorphological criteria for
rejection were classified in a semiquantitative scoring sys-
tem regarding the progress of the present inflammatory
infiltration, endothelitis, and necrosis, and received a score
ranging from 0 to 5 (where 0 Z normal; 1 Z inflammation
of undetermined significance; 2 Z minimal rejection;
3 Z mild rejection; 4 Z moderate rejection; and
5Z severe rejection). According to this scoring system, all
pancreas grafts received a score at each biopsy time point.
2.7. Animal rights
The study protocol was approved by the German Committee
for Animal Care, Karlsruhe, Germany. During the experi-
ment, all animals received humane care according to insti-
tutional guidelines established for the Animal Care Facility
at the University of Heidelberg, Heidelberg, Germany.
2.8. Statistical analysis
The analysis was performed using SPSS version 11.5 for
Windows (Stata Corp, College Station, TX, USA). AfterTable 1 The mean value of cardiovascular parameters and tem
Mean arterial pressure (mmHg) Heart
Before reperfusion After reperfusion Before reperf
UW 99.1  22.7 102.0  22.7 89.1  8.8
Modified HTK 104.2  15.6 88.8  10.5 80.0  11.6
Standard HTK 90.7  15.2 86.2  15.5 88.1  25.7
HTK Z histidine tryptophan ketoglutarate; UW Z University of Wiscoevaluating the distribution of the data with a Kolmogor-
oveSmirnov test, we used the ManneWhitney U or the
KruskaleWallis tests when needed. Repeated measurement
analysis was used for comparing the five predefined time
points (on the same dependent variable) in the three study
groups (UW, modified HTK, and standard HTK). All data
were expressed as mean  standard deviation. A p value
<0.05 was considered statistically significant.
3. Results
3.1. General findings
Twenty-three successfully transplanted animals with a cold
ischemia time of 10 hours were evaluated in three groups
with different preservation solutions: UW (nZ 7), modified
HTK (n Z 8), and standard HTK (n Z 8). All pigs were
followed-up for 7 days without mortality. The weights of all
animals in the mentioned groups on the implantation day
were 29  2.6 kg, 29.5  2.7 kg, and 31.3  4 kg in UW,
modified HTK, and standard HTK, respectively. At the end of
the follow-up period, the mean body weights were
29  2.3 kg in the UW group, 29.2  2.6 kg in the modified
HTK group, and 29.2  5 kg in the standard HTK group
without any significant differences at two time points or in
the studied groups. The anastomosing time (warm ischemia
time) was 62  5 minutes in the UW group, 55  8 minutes in
the modified HTK group, and 57  7 minutes in the standard
HTK group. Cold and warm ischemic times were not consid-
erably different among the experimental groups. The mean
values of all perioperative measurements of animals are
summarized in Table 1. There were no significant changes in
the cardiovascular parameters including MAP and heart rate
during graft implantation in the experimental groups.
Because of the use of warm blankets during the operation,
even the body temperature did not differ significantly among
the experimental groups. After removing the venous and
arterial clamps, all implanted pancreata showed, macro-
scopically, a good homogenous reperfusion. On Day 7 during
the reoperation, no signs of fluid collection or macroscopic
infection were noticed. All grafts showed a homogenous
colorwithout any evidence of vascular thrombosis or leakage
from the duodenal anastomosis.
3.2. Hematology and biochemistry findings
In donors, the blood samples were obtained to assess any
probable graft problems. The mean values of laboratory
results during organ procurement, perioperation, and
postoperation in different groups are reported in Table 2.perature in recipient animals during pancreas implantation.
rate (beat/min) Temperature (C)
usion After reperfusion Before reperfusion After reperfusion
86.7  16.8 36.0  0.6 35.3  0.5
84.2  10.0 36.6  0.8 36.0  1.1
87.7  20.8 36.8  0.6 36.9  0.7
nsin.
Table 2 The mean values of laboratory results in animals during organ procurement, graft implantation, and follow-up times.
Organ procurement Recipient
After reperfusion Day 1 Day 3 Day 7
Hb (g/dL) UW 10.0  0.7 9.0  0.4 9.0  0.8 10.0  1.9 9.0  0.7
Modified HTK 10.0  0.8 10.0  0.8 13.0  2.7 12.0  3.2 11.0  2.5
Standard HTK 11.0  0.8 10.0  1.7 12.0  1.5 11.0  1.4 11.0  1.7
Hct (%) UW 32.7  0.1 28.0  0.1 26.5  3.3 28.0  9.0 28.5  1.0
Modified HTK 31.0  2.0 32.0  4.0 37.0  7.0 34.0  8.0 33.0  7.0
Standard HTK 32.0  2.0 31.0  5.0 36.0  5.0 32.0  5.0 32.5  6.0
CRP (mg/L) UW <0.5 <0.5 <0.5 4.0  0.3 4.0  0.6
Modified HTK <0.5 <0.5 <0.5 4.0  1.1 4.0  0.7
Standard HTK <0.5 <0.5 <0.5 4.0  0.8 4.0  0.8
CRP Z C-reactive protein; Hb Z hemoglobin; Hct Z hematocrit; HTK Z histidineetryptophaneketoglutarate; UW Z University of
Wisconsin.
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matocrit, and C-reactive protein after implantation in all
experimental groups. Plasma amylase and lipase levels did
not differ significantly among the groups at all the pre-
defined time points. The insulin and glucose levels in
different time points are shown in Figures 4 and 5. Although
no significant difference in insulin level was seen between
the groups of modified HTK and standard HTK (p Z 0.65),
the pairwise comparisons showed that the insulin level in
the UW group during the five predefined time point follow-
ups is significantly higher compared with that of the
modified HTK (p Z 0.006) and standard HTK groups
(p Z 0.001). There were no significant differences in the
glucose level between the UW and modified HTK groups
(p Z 0.935), UW and standard HTK groups (p Z 0.131), as
well as modified HTK and standard HTK groups (pZ 0.138).
3.3. Pathological findings
Biopsies taken after the cold ischemia time and directly after
reperfusion generally showed normal pancreatic tissue or
sticking of neutrophils, irrespective of the various groups.Figure 4 Mean values and standard deviations of serum insulin in
experimental study (donor, after reperfusion, and 1st
HTK Z histidineetryptophaneketoglutarate; UW Z University of WBeyond this, one pig each in the UWand standard HTK groups
displayed infiltration of the acinar parenchyma by neutro-
phils, and one pig from the standard HTK group showed focal
fatty necrosis. After 7 days, more severe changes with
partially marked inflammatory infiltration and necrosis were
observed. Furthermore, varying extent of fatty necrosis with
accompanying inflammation was found in the majority of
samples. Based on histomorphological findings, seven of
eight (87.5%) pigs in the UW group displayed criteria of
moderate rejection or more, as did four of eight (50%) pigs in
the modified HTK group, and four of eight pigs (50%) in the
standard HTK group. Although pathological findings have
reported superior results in the HTK groups, these im-
provements in the histopathological structure showed no
significant difference between the solutions in different bi-
opsy phases (after cold ischemia phase, p Z 0.12; after
reperfusion, pZ 0.09; 7th day, pZ 0.35; Figure 6).
4. Discussion
Reducing the damage induced in cold ischemia is an
important factor for successful solid organ transplantation.three groups of UW, modified HTK, and standard HTK during the
day, 3rd day, and 7th day after transplantation).
isconsin.
Figure 5 Mean values and standard deviations of serum glucose in three groups (UW, modified HTK, and standard HTK) during the
experimental study (donor, after reperfusion, and 1st day, 3rd day, and 7th day after transplantation).
Modified HTK in PTx 71Over the past decade, the transplant centers have
increasingly used HTK solutions for abdominal organ pro-
curement as their primary solid organ preservation sol-
ution.24e26 This trend is attributable to the lower cost,
reduced risk of reperfusion hyperkalemia, and improved
microvasculature perfusion because of lower viscosity and
better cell preservation over a wider range of tempera-
tures.27,28 In the modified HTK solution, histidine was
partially substituted with N-acetyl-histidine, and chloride
was replaced with aspartate, glycine, alanine, and argi-
nine; LK 614, which is highly membrane-permeable because
it is small and lipophilic, is incorporated.20,29,30 To assess
the efficacy of the mentioned modifications, this study has
been planned to compare the modified HTK solution with
the two currently clinically established preservation solu-
tions: UW (Viaspan) and HTK (Custodiol).
Regarding the pig characteristics, owing to similarities in
the immune system, physiology, and technical approach
from the surgical points of view, the pig model is consid-
ered a well-established model for experimental studies of
PTx.31 Furthermore, both exocrine and endocrine aspects
of the pig pancreas are closely similar to those of the
human pancreas.32 Because the operating team had a long-
term experience in PTx on pigs (and because the anesthesia
and surgical techniques were standardized), there were no
technique-related complications. The result of monitoring
during operation also showed a stable situation without
significant differences among the groups in terms of MAP,
heart rate, and temperature. Additionally, the operation
duration, laboratory tests (hemoglobin and hematocrit),
and cold and warm ischemia time were approximately
identical among groups. All transplanted animals survived
for 7 days, regardless of the preservation solution used.
In our study, for an adequate monitoring of the trans-
planted pancreases, the native pancreata were removed
prior to the implantation of the graft. The level of serum
insulin compared to serum glucose is essentially a sign of
pancreas function. The insulin levels markedly decreased,
whereas the levels of glucose increased, when the function
of the pancreas decreased, such as during the earlypostoperative days following transplantation. As we have
shown, the level of insulin was extremely low in all groups
after reperfusion. In the 1st posttransplantation day, there
was a rise in insulin levels in all groups; this trend continued
until the 3rd postoperative day. The rise of insulin was
significantly better in the UW group compared to the
modified HTK and standard HTK groups. Subsequently, a
slight reduction occurred during the next 4 days. On the 7th
day, the level of insulin in the UW group was significantly
higher compared to that in both HTK groups. The serum
glucose level during procurement was in the normal range.
After reperfusion, a slight increase occurred in the glucose
level in all groups. On the 3rd posttransplantation day, there
was a significant decrease in the glucose level in the UW
group, which increased on Day 7 to the normal range.
Meanwhile, we did not notice a significant difference in
glucose levels between the three studied groups. There-
fore, regarding insulin and glucose levels in the studied
groups, it seems that pancreas grafts had acceptable
endocrine function.
Pancreas graft inflammation might be evaluated by
valuable markers such as the general condition of re-
cipients and the levels of C-reactive protein.33 Although all
the recipients in these three groups had received intra-
vascular antibiotics, the C-reactive protein increased
inconsiderably on Day 3. Regarding the good general con-
dition of recipients and reported insulin and glucose levels
during the five predefined time points, the increased level
of CRP could be an indication of a mild inflammation in the
implanted pancreas.
We have evaluated the histopathological changes in the
transplanted organs [based on a scoring system that has
been used by Drachenberg et al23 in each group during
three time point biopsiesd(1) at the end of the cold
ischemia time (prior to reperfusion), (2) after reperfusion,
and (3) on the 7th day after the operation]. All samples
were fixed in formaldehyde 5% and evaluated by a pathol-
ogist. The results showed moderate to severe rejection in
four out of eight samples of each of the HTK groups and six
out of seven samples in the UW group. The same duration of
Figure 6 Comparison of the histopathological results based
on the semiquantitative scores through KruskaleWallis test.
The vertical line is the calculated score regarding the semi-
quantitative scoring system. The rectangles depict the range
between the lower (25%) and upper (75%) quarter of the
evaluation. The horizontal line in the middle of the rectangles
represents the median (CIT Z cold ischemia time).
72 M. Esmaeilzadeh et al.cold ischemia time and inconsiderable differences in all
other parameters among the three groups may be attrib-
utable to a potent buffer system in HTK groups and LK614
playing its role as a protective factor on the surface of
endothelial cells19,20,30 in modified HTK. The rate of mod-
erate or severe rejection detected in pathological evalua-
tion well reflected the rate of the respective clinically
detected organ rejection. In addition to the inflammation
and necrosis related to organ rejection, fatty necrosis was
observed to a variable degree in the majority of the sam-
ples of the analyzed subgroups. Based on our pathological
findings, a varying extent of fatty necrosis with accompa-
nying inflammation was found in different grades in histo-
pathological examination. Most likely, this fatty necrosis
could occur as a result of the surgical intervention.
Therefore, in the context of organ rejection, fatty necrosis,
eventually being associated with reactive-inflammatory
changes, should be evaluated irrespective of acinarnecrosis and inflammationdthe latter two represent
important criteria for estimating the organ rejection grade.
As we have shown, the level of insulin in the UW group
during the five predefined time point follow-ups was
significantly higher compared to that in both HTK groups,
although there were no significant differences in the
glucose level between the groups. By contrast, the histo-
pathological results showed a trend of a higher grade of
rejection of pancreas tissue in the UW group compared to
both HTK groups. This discrepancy might be explained by a
nonlinear relationship between insulin levels and the per-
centage of b cell, which has been previously described and
can be maintained despite a significant loss of b cells.34
Pancreatic b cell mass can reach pathological conditions
in which the mass is below a critical threshold. It has been
shown that a loss of w80e90% of b cell mass prior to the
onset of hypoinsulinemia is considerable.35 Theoretically,
this could explain why more pathological cell injury in the
UW groupdwhich was not significantddoes not cause a
substantial reduction in insulin values, although the insulin
levels were in the normal range among all groups.
In conclusion, the modified HTK solution could preserve
the pancreas graft with similar outcomes to those of stan-
dard HTK and UW solutions without any significant differ-
ences. Although the pathological finding in the UW groupwas
not as good as that in the modified HTK and standard HTK
solutions, the insulin levels were significantly better in
comparison with that in the HTK groups. However, further
prospective experimental and clinical trials will be required
with extended criteria (e.g., long cold ischemia time) to
compare modified HTK with standard HTK and UW solutions.
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